Back to Search
Start Over
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy.
- Source :
-
Leukemia [Leukemia] 2014 Aug; Vol. 28 (8), pp. 1759-62. Date of Electronic Publication: 2014 Mar 28. - Publication Year :
- 2014
- Subjects :
- ADP-ribosyl Cyclase 1 analysis
Antigens, CD analysis
Antigens, CD34 analysis
Humans
Immunotherapy
Interleukin-12 physiology
Leukemia, Myeloid, Acute pathology
Leukemia, Myeloid, Acute therapy
Nucleophosmin
Receptors, Interleukin-12 genetics
Leukemia, Myeloid, Acute genetics
Mutation
Neoplastic Stem Cells metabolism
Nuclear Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 28
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Report
- Accession number :
- 24675106
- Full Text :
- https://doi.org/10.1038/leu.2014.116